The Eurofins Scientific group, listed on the Paris Stock Exchange and among the world leading companies in the Life Sciences sector, has acquired a majority stake in AB Analitica, a Padua-based company leader in the molecular diagnostics.

 

Eurofins Scientific achieved consolidated revenues of around €7 billion in 2024 with a network of over 950 laboratories in 60 countries, providing diagnostics for the pharmaceutical, food, environmental and consumer product sectors.

 

AB Analitica, founded in 1990, is a leading company in the molecular diagnostics, designing, developing, and marketing diagnostic systems for research and molecular analysis in fields such as microbiology, virology, onco-hematology, and genetics.

 

With the acquisition of a majority stake in AB Analitica the Eurofins Group pursues its strategy of investing in companies of excellence in the field of molecular diagnostics.

 

The current shareholders of AB Analitica will support the new partner keeping a minority stake and their operational roles.

 

The sellers were assisted by Credem Euromobiliare Private Banking as exclusive financial advisor.